Front. Physiol. Frontiers in Physiology Front. Physiol. 1664-042X Frontiers Media S.A. 10.3389/fphys.2014.00082 Physiology Mini Review Article Gap junction modulation and its implications for heart function Kurtenbach Stefan 1 * Kurtenbach Sarah 1 Zoidl Georg 1 2 3 1Department of Psychology, Faculty of Health, York University Toronto, ON, Canada 2Department of Biology, Faculty of Science, York University Toronto, ON, Canada 3Center for Vision Research, York University Toronto, ON, Canada

Edited by: David C. Spray, Albert Einstein College of Medicine, USA

Reviewed by: Michael Tamkun, Colorado State University, USA; Francisco F. De-Miguel, Universidad Nacional Autonoma de Mexico, Mexico

*Correspondence: Stefan Kurtenbach, Molecular and Cellular Neuroscience, Department of Psychology, Faculty of Health, York University, LSB 323A, 4700 Keele Street Toronto, ON M3J 1P3, Canada e-mail: stefan.kurtenbach@me.com

This article was submitted to Membrane Physiology and Membrane Biophysics, a section of the journal Frontiers in Physiology.

 27 02 2014 2014 5 82 28 11 2013 10 02 2014 Copyright © 2014 Kurtenbach, Kurtenbach and Zoidl. 2014

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Gap junction communication (GJC) mediated by connexins is critical for heart function. To gain insight into the causal relationship of molecular mechanisms of disease pathology, it is important to understand which mechanisms contribute to impairment of gap junctional communication. Here, we present an update on the known modulators of connexins, including various interaction partners, kinases, and signaling cascades. This gap junction network (GJN) can serve as a blueprint for data mining approaches exploring the growing number of publicly available data sets from experimental and clinical studies.

 gap junction communication connexin heart interactome signaling pathway Gap junction communication in health and disease

Gap junction communication (GJC) describes the electrical and metabolic coupling of cells through specialized cell contacts called gap junctions. In vertebrates, gap junctions are present in most tissues having important roles in development, growth regulation, tissue homeostasis, and communication. They assemble from homo- or hetero-hexameric connexin hemichannels encoded by 20 (rodents) or 21 (human) different genes (Söhl et al., 2005). GJC has been studied in great detail for the last 50 years. These studies emphasized important molecular, biophysical properties, and physiological roles of connexin channels. Other studies revealed connexin structures down to atomic resolution (Maeda et al., 2009; Grosely and Sorgen, 2013) and a multitude of regulatory mechanisms controlling the entire life cycle of these channels from transcription, post-translational modification, to removal of gap junctions and degradation (Laird, 2006; Johnstone et al., 2012a; Su et al., 2012; Thévenin et al., 2013). More recent work demonstrated connexin hemichannel functions under physiological conditions (Bruzzone et al., 2001; Anselmi et al., 2008; Garré et al., 2010) and evidence for channel independent function, e.g., in cell growth and death (Vinken et al., 2012) or migration (Kameritsch et al., 2012). Mutations in connexins were discovered in inherited human diseases like oculodentodigital dysplasia (ODDD, Cx43, GJA1; Huang et al., 2013), X-linked Charcot-Marie-Tooth disease (Cx32, GJB1; Scherer and Kleopa, 2012), Pelizaeus-Merzbacher-like disease or a milder spastic paraplegia (Cx47; Kleopa et al., 2010), Vohwinkel syndrome as well as Keratitis-Icthyosis-Deafness (KID) syndrome (Cx26, GJB2; Lee and White, 2009; Xu and Nicholson, 2013), Erythrokeratodermia variabilis (Cx31, GJB3; Cx30.3, GJB4), Clouston syndrome (Cx30, GJB6) or secondary lymphedema following breast cancer treatment (Cx47, GJC2; Finegold et al., 2012). Furthermore, transcriptional and post-transcriptional alterations and dysfunctional degradation by autophagy (Lichtenstein et al., 2011; Fong et al., 2012) may represent indirect mechanisms causing impaired GJC. Today, a causal relationship, e.g., in the context of seizures (Li et al., 2001; Gajda et al., 2005; Samoilova et al., 2008), cerebral ischemia (Contreras et al., 2004; Talhouk et al., 2008; Orellana et al., 2010), autism (Fatemi et al., 2008), schizophrenia (Meyer et al., 2002; Aleksic et al., 2007), and after trauma (Frantseva et al., 2002) seems plausible. Thus, understanding the exact roles of GJC in health and disease is a highly relevant and timely objective in biomedical and preclinical research. Transcriptome studies have started to provide valuable insight into the consequences of altered connexin expression in animal models (Spray and Iacobas, 2007; Iacobas et al., 2012, 2007a), exploring the use of coordination analysis of gene expression as a strategy to identify connexin related gene networks. The huge amount of transcriptome data available in public databases, together with more sophisticated data processing tools, suggest that investigating transcriptional changes within a physiologically relevant “gap junction network” (GJN) will have wide application potential.

 Modulation of gap junction communication

The major cardiac connexin proteins are Cx40 (GJA5), Cx43 (GJA1), and Cx45 (GJC1), having distinct expression patterns and essential roles in propagation of action potentials, metabolic coupling, tissue homeostasis and heart development (Lo, 2000; Nishii et al., 2001; Rohr, 2004; Bernstein and Morley, 2006; Zacchigna et al., 2009; Jansen et al., 2010). Given these important functions, it is not surprising that GJC has been associated with various heart diseases (Jongsma and Wilders, 2000; Severs, 2001; Severs et al., 2004, 2008; Tribulová et al., 2008; Rodríguez-Sinovas et al., 2012; Verheule and Kaese, 2013). Here, we will focus on interacting and modulating proteins, clustered in functional groups, forming the basis for a draft GJN (Figure 1). A complete list of proteins, isoforms, and putative interactions in the GJN can be found in Table 1, a list of proven interactions in Table 2, while functional evidence is presented below. We will not discuss the structurally related, non-gap junction forming pannexins, or LRRC8 (Abascal and Zardoya, 2012), although it is interesting to note that pannexins release cardioprotectants during ischemic events in the heart (Wang et al., 2009; Vessey et al., 2010, 2011; Rodríguez-Sinovas et al., 2012).

Simplified summary of the gap junction network. This cartoon summarizes important signaling pathways, modulators, and interacting proteins of connexins, which converge exemplarily on a (green) connexin gap junction channel. The major functional groups outlined in the main text have been color-coded and relations between groups indicated by arrows. Further, phosphorylation (P) and dephosphorylation (-P) is highlighted. Note that the depicted pathways/interactions will vary for individual connexins. The gap junction network includes G proteins (light blue), cyclases (dark blue), kinases (violet), MAPK/ERK related signaling pathways (orange), receptors (red), scaffolding and junctional proteins (pink), cytoskeleton (dark pink), and cell cycle associated proteins (yellow).

A draft of a gap junction network gene list.

ADCY1, ADCY10, ADCY2, ADCY3, ADCY4, ADCY5, ADCY6, ADCY7, ADCY8, ADCY9, AQP1, AQP2, AQP3, AQP4, AQP5, AQP6, AQP7, AQP8, AQP9, AQP10, AQP11, AQP12A, AQP12B, BAX, CALM1, CALM2, CALM3, CAMK1, CAMK1D, CAMK1G, CAMK2A, CAMK2B, CAMK2D, CAMK2G, CAMK4, CASK, CAV1, CAV2, CAV3, CCNE1, CDC2, CDH1, CDH10, CDH11, CDH12, CDH13, CDH14, CDH15, CDH16, CDH17, CDH18, CDH19, CDH2, CDH20, CDH3, CDH4, CDH5, CDH6, CDH7, CDH8, CDH9, CIP85, CSNK1A1, CSNK1A1L, CSNK1D, CSNK1G1, CSNK1G2, CSNK1G3, CSNK2A1, CSNK2A2, CSNK2B, CTNNA1, CTNNA2, CTNNA3, CTNNAL1, CTNNB1, CTNNBL1, CTNND1, CTNND2, DBN1, EGFR, GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, GNA11, GNA12, GNA13, GNA14, GNA15, GNAI1, GNAI2, GNAI3, GNAL, GNAO1, GNAQ, GNAS, GNAT1, GNAT2, GNAT3, GNAZ, GNB1, GNB1L, GNB2, GNB2L1, GNB3, GNB4, GNB5, GNG10, GNG11, GNG12, GNG13, GNG2, GNG3, GNG4, GNG5, GNG7, GNG8, GNGT1, GNGT2, GRB2, GUCY1A2, GUCY1A3, GUCY1B2, GUCY1B3, GUCY2A, GUCY2B, GUCY2C, GUCY2E, HRAS, HSP70-1A, HSP70RY, HSP70-4, HSP70-1B, HSP70T, HSP70-3, KRAS, MAP2K1, MAP2K2, MAP2K3, MAP2K4, MAP2K5, MAP2K6, MAP2K7, MAP3K1, MAP3K10, MAP3K11, MAP3K12, MAP3K13, MAP3K14, MAP3K15, MAP3K2, MAP3K3, MAP3K4, MAP3K5, MAP3K6, MAP3K7, MAP3K8, MAP3K9, MAP4K1, MAP4K2, MAP4K3, MAP4K4, MAP4K5, MAPK1, MAPK10, MAPK11, MAPK12, MAPK13, MAPK14, MAPK15, MAPK3, MAPK4, MAPK6, MAPK7, MAPK8, MAPK9, MLLT4, MPDZ, NRAS, OCLN, P2-receptor, P2RX7, P2RY1, PANX1, PANX2, PANX3, PDGFRA, PDGFRB, PDGFRL, PKP1, PKP2, PKP3, PKP4, PLCB1, PLCB2, PLCB3, PLCB4, PLCD1, PLCD3, PLCD4, PLCE1, PLCG1, PLCG2, PLCH1, PLCH2, PLCL1, PLCL2, PLCZ1, PRKAA1, PRKAA2, PRKAB1, PRKAB2, PRKACA, PRKACB, PRKACG, PRKAG1, PRKAG2, PRKAG3, PRKAR1A, PRKAR1B, PRKAR2A, PRKAR2B, PRKCA, PRKCB, PRKCD, PRKCDBP, PRKCE, PRKCG, PRKCH, PRKCI, PRKCQ, PRKCZ, PRKG1, PRKG2, PTPRM, RAF1, SOS1, SOS2, SRC, TJAP1, TJP1, TJP2, TJP3, TSG101, TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBA8, TUBAL3, TUBB1, TUBB2A, TUBB2C, TUBB3, TUBB4, TUBB6, TUBD1, TUBE1, TUBG1, TUBG2, VCL

Summarizing GJC/connexin interaction/modulating proteins, we propose a draft of a GJN forming the blueprint to investigate the role of GJC. Known GJC modulators, as well as putative ones (isoforms and other closely related proteins) are included, with the intent to foster research on GJN modulation in health and disease.

Summary of connexin interacting proteins.

Interacting protein Connexin Type of detection References
CELL–CELL JUNCTIONAL AND SCAFFOLDING PROTEINS
α-catenin GJ co-loc, EM, FRIL Fujimoto et al., 1997
β-catenin Cx43 co-loc in cardiac myocytes, β-catenin-IP (N) Ai et al., 2000; Lee and White, 2009
actin Cx43 co-loc Wall et al., 2007; Smyth et al., 2012
AF6 Cx36 AF6-IP (N), Cx36-IP (N), co-loc Li et al., 2012
AGS8 Cx43 IVB, co-loc Sato et al., 2009
CASK Cx36 IVB, co-loc, Far-WB, CASK-IP (N, RE) Márquez-Rosado et al., 2012
CAV1 Cx43 CAV1-IP (RE), co-loc, IVB Langlois et al., 2008
CAV2 Cx43 CAV2-IP (RE), co-loc, IVB Langlois et al., 2008
CAV3 Cx43 CAV3-IP (N), co-loc, IVB Liu et al., 2010
CDH1 GJ co-loc, EM, FRIL Fujimoto et al., 1997
CDH2 Cx43 N-cadherin-IP (N), co-loc Lee and White, 2009
drebrin Cx43 co-loc, IVB Butkevich et al., 2004
MUPP1 Cx36 Cx36-IP (N), MUPP1-IP (N), co-loc Li et al., 2012
occludin Cx43 occludin-IP (RE), co-loc Kojima et al., 1999
p120ctn Cx43 co-loc Xu et al., 2001
PKP2 Cx43 PKP2-IP (N) Lee and White, 2009; Sato et al., 2011
tubulin Cx43 co-loc, IVB Giepmans et al., 2001a,b
vinculin Cx43 AB-array, Cx43-IP (N) Iacobas et al., 2007a,b
ZO-1 Cx43 co-loc cardiac myocytes, ZO1-IP (RE, N), Cx43-IP (RE), IVB Giepmans and Moolenaar, 1998; Toyofuku et al., 1998
Cx45 ZO-1-IP (RE), co-loc, Y2H (PDZ Domain), IVB Kausalya et al., 2001
ZO-2 Cx43 IVB, ZO2-IP (N), Cx43-IP (N), co-loc, Far-WB Singh et al., 2005
ZO-3 Cx45 Y2H (PDZ domains) Kausalya et al., 2001
KINASES
PKA Cx35 IVP Ouyang et al., 2005
Cx36 IVP Urschel et al., 2006
Cx50 IVP, in vivo phosphorylation, Liu et al., 2011a,b
PKC Cx43 PKCα-IP (N), Cx43-IP (N; PKCα, PKCε, PKCδ), co-loc (PKCα, PKCε, PKCδ), IVP (PKCδ), PKCδ-IP Bowling et al., 2001; Niger et al., 2010
PKG Cx35 IVP Patel et al., 2006
PKG Cx43 IVP Kwak et al., 1995; Patel et al., 2006
CaMKII Cx43 IVP, co-loc Hund et al., 2008; Huang et al., 2011
calmodulin Cx32 co-loc Peracchia et al., 2000
CKI Cx49 IVP Cheng and Louis, 1999
Cx43 IVP, Cx43-IP (N) Cooper and Lampe, 2002
CKII Cx45.6(av) IVP, in vivo phosphorylation Yin, 2000
MAPK7/ERK5 Cx43 IVP, ERK5-IP (RE), Cx43-IP (RE) Cameron et al., 2003
c-Src Cx43 Cx43-IP (N, RE) Toyofuku et al., 2001; Li et al., 2009
CIP85 Cx43 Co-loc, CIP85-IP (RE, N) Lan et al., 2005
RECEPTORS
RPTPμ Cx43 RPTPμ-IP (RE), Cx43-IP (N, RE) Giepmans et al., 2003
AQP0 Cx45.6(av) Cx45.6-IP (N), co-loc Yu and Jiang, 2004; Yu et al., 2005
Cx56(av) Cx56-IP (N) Yu and Jiang, 2004
P2X7 Cx43 Cx43-IP (N), P2X7 (N), co-loc, AB-array, Fortes et al., 2004; Iacobas et al., 2007a,b
CELL CYCLE/CELL DEATH
cyclin E Cx43 co-loc, Cx43-IP (N), cyclin E-IP (N) Johnstone et al., 2012a,b
HSP70 Cx43 co-loc, Cx43-IP (N) Hatakeyama et al., 2013
TGS101 Cx43 Y2H, TGS101-IP (N), co-loc Auth et al., 2009
Cx36 Y2H, TGS101-IP (N) Auth et al., 2009
Cx30.2 Y2H Auth et al., 2009
BAX Cx43 Cx43-IP (RE) Sun et al., 2012

Summary of connexin interacting proteins. This table summarizes documented interactions described in the text and the detection methods used. It does not include indirect interactions with regulatory pathways. Abbreviations in alphabetic order: AB-array, antibody array; av, avian connexin; co-loc, co-localization in cells or tissues; IVB, in vitro binding, binding of peptides or functional domains; Far-WB, Far western blot; IVP, in vitro phosphorylation; N, native, non-transfected tissues, cells, or cell lines; RE, one or both IP partners were expressed in recombinant cells; Y2H, yeast two hybrid assay.

 Cell-cell junctional and scaffolding proteins

A shared communality among connexins is the binding to junctional, scaffolding and cytoskeletal/transport proteins. Interactions between connexins and the tight junction proteins ZO-1, ZO-2, and ZO-3 (TJP1, TJP2, TJP3) vary regarding different connexin and ZO proteins (Giepmans and Moolenaar, 1998; Toyofuku et al., 1998; Kausalya et al., 2001), regulating connexon to gap junction transition (Rhett et al., 2011) and, as shown for ZO-1, can be regulated by c-Src in cardiac myocytes (Toyofuku et al., 2001). Increased interaction of ZO-1 with Cx43 plays a role in Cx43 down-regulation and reduced Cx43 gap junction size in congestive heart failure (Bruce et al., 2008). Cell adhesion proteins like E-cadherin (CDH1) and α-catenin are co-localized in newly formed gap junctions (Fujimoto et al., 1997), and E-cadherin mediated cell–cell contacts were shown to increase GJC (Jongen et al., 1991). p120ctn (CTNND1) (Xu et al., 2001) and β-catenin (CTNNB1) (Ai et al., 2000) also co-localize with Cx43, and Cx43 was further found to immunoprecipitate with β-catenin (Li et al., 2009). N-cadherin (CDH2)/connexin interactions were also reported (Li et al., 2009). CDH2 antibodies inhibit gap junction formation (Meyer et al., 1992), and cardiac specific CDH2 knockout in mice causes reduced GJC and sudden death (Li et al., 2005). Vinculin (VCL) interacts with connexins (Iacobas et al., 2007b), and cardiac myocyte specific VCL knockout caused Cx43 dislocation, dilated cardiomyopathy, and sudden death (Zemljic-Harpf et al., 2007). VCL also binds directly to ZO-1, stabilizing gap junctions in the heart (Zemljic-Harpf et al., 2014). The tight junction protein occludin (OCLN) was shown to interact with Cx32 (Kojima et al., 1999) and ZO-1 as well as ZO-2 (Furuse, 1994; Itoh et al., 1999).

AGS8 (FNDC1) forms a scaffold for Gβγ subunits and Cx43 and elicits phosphorylation and subsequent internalization, an effect involved in hypoxia-induced apoptosis in cardiomyocytes (Sato et al., 2009). In the brain, the scaffolding proteins MUPP1 (MPDZ) and AF6 (MLLT4) interact with Cx36 (Li et al., 2012). Membrane targeting, cellular migration and wound healing are modulated by Cx43 and interaction with the multidomain scaffolding protein CASK (Márquez-Rosado et al., 2012). Further, all three known human caveolins (CAV), a group of proteins found in lipid rafts and the membrane, interact with Cx43 (Langlois et al., 2008; Liu et al., 2010), increasing GJC (shown for CAV1 and CAV2). Drebrin (DBN1) interacts with Cx43 maintaining Cx43-containing gap junctions in their functional state (Butkevich et al., 2004), likely involving further interactions with the cytoskeleton.

 Cytoskeleton

Connexins are known to directly interact with α-and β-tubulin (Giepmans et al., 2001a,b). There are multiple different tubulin subunits and regional differences in their expression may be linked to schizophrenia (Moehle et al., 2012). Direct interactions of connexins with actin were not reported, but connexins co-localize with actin, which was linked to anterograde Cx43 trafficking (Wall et al., 2007; Smyth et al., 2012). Interactions with actin can be mediated via various scaffolding proteins including drebrin (Butkevich et al., 2004; Majoul et al., 2007) and ZO-1 (Rhett et al., 2011). Further, Cx43 interacts with plakophilin-2 (PKP2) (Li et al., 2009; Sato et al., 2011), a protein linking cadherins to intermediate filaments in the cytoskeleton. Finally, expression of six cytoskeletal proteins (actin, tropomyosin, microtubule-associated protein RP/EB1, transgelin, GFAP, cofilin-1) were differentially regulated when Cx43 expression was targeted in astrocytes with small interfering (si)RNAs (Olk et al., 2010).

 Kinases

Phosphorylation of connexins has various effects on GJC and plays major roles at several steps of the connexin lifecycle, including trafficking, assembly/disassembly, degradation, and gating (Lampe and Lau, 2004). PKA can phosphorylate connexins and promote their synthesis and assembly/stability (Imanaga et al., 2004; Ouyang et al., 2005; Zhang et al., 2005; Urschel et al., 2006; Liu et al., 2011a). PKCs (PRKC) modulate Cx43, including direct phosphorylation through PKCε (PRKCE), and increased phosphorylation mediated by PKCα (PRKCA) (Bowling et al., 2001). Further, PKCδ (PRKCD) was shown to bind to Cx43 (Niger et al., 2010). PKCs are considered a therapeutic target due to the expression of multiple PKCs in the heart and their expression changes and contribution to heart diseases (Liu et al., 2009; Palaniyandi et al., 2009). The cGMP dependent Protein kinase G (cGK, PKG, PRKG) was also reported to phosphorylate connexins and modulate their expression (Kwak et al., 1995; Patel et al., 2006; Joshi et al., 2012). Mammals inherit two PRKGs, cGKI (PRKG1), and cGKII (PRKG2), where PRKG1 is the main PRK in the heart. PRKG1 has well-known functions in the cardiovascular system, including excitation-contraction coupling, contractility, CM hypertrophic remodeling and more, where elevated cGMP levels protect against adverse ventricular remodeling (Balligand and Hammond, 2013; Frantz et al., 2013). In the failing human heart, PKA, as well as PKC and PKG, can phosphorylate cardiac ryanodine receptors, resulting in defective channel function due to increased sensitivity (Takasago et al., 1991; Marx et al., 2000). Ca2+/calmodulin-dependent protein kinase II (CaMKII) can phosphorylate Cx43, and its activation and/or increased expression occurs in cardiac disease states like infarction, hypertrophy, and myocardial ischemia (see Erickson and Anderson, 2008; Huang et al., 2011 and references within) and is therefore considered a drug target in heart failure (Bers, 2010). The δ (CAMK2D) subunit is the highest expressed CaMKII in the heart, besides the γ (CAMK2G) subunit being expressed at lower levels (Schworer et al., 1993; Edman and Schulman, 1994). Calmodulin (CaM) activates CaMKII, and also directly modulates connexin gating properties and mediating Ca2+-induced uncoupling of gap junctions (review: Zou et al., 2014). Connexins can be modulated by casein kinase 1 (CK1) and CK2 (Cheng and Louis, 1999; Yin, 2000). Besides the finding that CK1δ (CSNK1D) regulates Cx43 gap junction assembly (Cooper and Lampe, 2002), little is known about which CKs targets for other connexins. CK2α1 dependent phosphorylation may be involved in the development of cardiac hypertrophy (Eom et al., 2011).

 Map kinase signaling cascades

The mitogen-activated protein kinase (MAPK) cascades are key intracellular signaling pathways regulating diverse cellular functions such as proliferation, differentiation, survival, development, stress response, and apoptosis. Multiple MAPK cascades have been identified, and although often described as linear, they display significant cross talk (Keshet and Seger, 2010). In the heart, H-Ras, K-Ras, and N-Ras are expressed (Potenza et al., 2005). MAPKs have functions in heart development and are also involved in heart disease formation (Rose et al., 2010). MAPK phosphorylation of connexins is well-documented (reviews: Giepmans, 2004; Solan and Lampe, 2005), e.g., MAPK7/ERK5 was reported to phosphorylate and associate with Cx43, regulating gap junction uncoupling (Cameron et al., 2003). The non-receptor protein tyrosine kinase protein c-Src inhibits the interaction of Cx43 and ZO-1 in cardiac myocytes (Toyofuku et al., 2001). Further, c-Src activation was shown to inhibit gap junctional coupling and remodeling in ischemic heart disease (review: Giepmans, 2004; Rutledge et al., 2012). A Rab-GAP-like protein, CIP85, interacts with Cx43 and induce its internalization and degradation (Lan et al., 2005; Cochrane et al., 2013).

 Heterotrimeric G-proteins

G proteins can interact with GJC by their activation/inhibition of different signaling cascades, e.g., via adenylyl cyclase or phospholipase C (see below). General consent is that GNAI2 is the main Giα in the heart, GNAI3 is expressed in lower amounts and GNAI1 is not expressed (Eschenhagen et al., 1992). However, there are few studies investigating expression of GNAI1 in detail. One newer study reports some cardiac GNAI1 expression (Dizayee et al., 2011) in the heart, alongside the knowledge of its expression in erythrocytes (Olearczyk et al., 2004) and thrombocytes (Patel et al., 2003). GNAI2 is thought to be up-regulated in various heart diseases, but maybe not in ischemic heart disease (ICM) (Feldman et al., 1988; Neumann et al., 1988; Böhm et al., 1990; Eschenhagen et al., 1992). Lack of Gαo leads to tachycardia and defects in short-term heart rate dynamics (Zuberi et al., 2008). Go and Gi may be involved in gap junction assembly, as pertussis toxin (PTX) sensitive G proteins were linked to Cx43 trafficking (Lampe et al., 2001). Overexpression of Gs(GNAS) causes many features of dilated cardiomyopathy (DCM) (Iwase et al., 1997), and haplotypes causing different expression levels of Gshave been found in humans (Frey et al., 2009), providing a putative link to heart disease risk. Gq (GNAQ) overexpression leads to heart hypertrophy and contractile failure in transgenic mice (D'Angelo et al., 1997; Fan et al., 2005), and knockout prevents ventricular hypertrophy in response to pressure-overload (Wettschureck et al., 2001). Gα13 regulates the expression of hypertrophic and fibrotic genes in cardiomyocytes, and inactivation prevents cardiac decompensation (Finn, 1999; Takefuji et al., 2012).

 Cyclases and phospholipase C

Modulators of the soluble guanylate cyclase (sGC, GUCY) are promising new drugs for heart failure treatment (Mitrovic et al., 2011). sGC is a heterodimer composed of one α (GUCYA), and one heme-binding β domain (GUCYB), of which sGCα1β1 is the principal heteromer in the heart (see Mitrovic et al., 2011 and references within). Adenylyl cyclase type III (ADCY) is considered a therapeutic target for heart diseases, where from 10 known ADCYs ADCY5 and ADCY6 are the predominant ones in the heart, expressed in a development-dependent way (e.g., Feldman, 2002 and references within), but several others are also expressed (Ludwig and Seuwen, 2002). Phospholipase C (PLC) cleaves phosphatidylinositol 4,5-bisphosphate (PIP2) into DAG and inositol 1,4,5-trisphosphate (IP3). DAG remains bound to the membrane, and IP3 is released as a soluble structure into the cytosol activating IP3 calcium channels in the smooth endoplasmic reticulum. In addition, calcium and DAG activate PKC. A majority of the 15 known PLCs is present in the heart and some were linked to heart dysfunction (Schwertz and Halverson, 1992; Meij et al., 1997; Hwang et al., 2004; Mangat et al., 2006; Ichise et al., 2009; Otaegui et al., 2010). PLCβ3 was reported to co-localize with Cx43, via the scaffolding protein ZO-1 (see below), where localized changes in PIP2 levels dictate channel inhibition (Van Zeijl et al., 2007).

 Receptors

Connexins interact with various other membrane proteins. The receptor protein tyrosine phosphatase (PTP) family regulates a variety of cellular processes including cell growth, differentiation, and mitotic cycle. RPTPμ (PTPRM) can bind and possibly dephosphorylate Cx43, counteracting c-Src phosphorylation, and preventing channel closure (Giepmans et al., 2003). The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase of the ErbB family. EGFR activation led to connexin phosphorylation and increased cytosolic localization of Cx43 possibly via the PI3/Akt signaling pathway (Díez et al., 1998; Abdelmohsen et al., 2003; Dubé et al., 2012). Platelet-derived growth factor receptors (PDGFRs) are receptors with intracellular tyrosine kinase activity, initiating intracellular signaling through the MAPK, PI3K, and PKCγ pathways. PDGFR activation was shown to lead to Cx43 phosphorylation by MAPK signaling (Hossain et al., 1999a,b, 1998a,b; Shen et al., 2013). PDGFRs have a vital role to load-induced cardiac stress response, angiogenesis, and regeneration (Schatteman et al., 1995; Van den Akker et al., 2008; Bleyl et al., 2010; Chintalgattu et al., 2010; Kim et al., 2010; Chong et al., 2013). The cystic fibrosis transmembrane conductance regulator (CFTR) regulates GJC possibly via a complex mechanism involving c-Src, modulating voltage sensitivity and gating. Further, functional interaction of gap junctions, CFTR and glutamate receptors (GluRs) were reported, although the molecular mechanism is unclear (review: Chanson et al., 2007). GluRs were found in the human myocardium, conducting system, nerve fibers, and intramural ganglia cells (Gill et al., 2007), and glutamate changes intracellular calcium oscillations in cultured rat myocardial cells (Winter and Baker, 1995). Together, GluRs are likely to play a physiological role in heart functions including contraction and rhythm, although their precise role is still elusive. Various aquaporins (AQP) are expressed in the heart, and although the information available is still limited, they were reported to mediate water flux across endothelial membranes, modulate calcium signaling, and nutrient delivery to the heart (Rutkovskiy et al., 2013). AQP0 was shown to interact with gap junctions and in particular with Cx50 in differentiating lens fibers (Yu and Jiang, 2004), enhancing gap junctional coupling (Liu et al., 2011b), suggesting a putative role for AQP/connexin interactions in the heart. Finally, interactions between connexins and purinergic receptors provide an interesting link of connexins to ATP signaling (Fortes et al., 2004; Iacobas et al., 2007b).

 Cell cycle/cell death

Beyond interactions at the plasma membrane and cytosol, connexins can interact with proteins shuttling between cytoplasm and nucleus, or proteins located in mitochondria. Cx43 interacts with cyclin E (CCNE1), for example after MAPK phosphorylation, promoting smooth muscle cell proliferation (Johnstone et al., 2012b). Cx43 also competes with cyclin D1 for binding to heat shock protein 70 (HSP70) (Hatakeyama et al., 2013). Further, degradation of connexins was linked to binding to tumor susceptibility gene 101 (TSG101), an ubiquitin–conjugating enzyme associated with the cell cycle, turnover of proteins, and transcriptional regulation (Auth et al., 2009). Cyclin-dependent kinase 2 (CDC2) was shown to phosphorylate Cx43 in a cell-cycle dependent manner (Kanemitsu et al., 1998; Lampe et al., 1998). Connexins also interact with BAX, a member of the Bcl-2 protein family located in the outer mitochondrial membrane, to regulate apoptosis (Sun et al., 2012).

 Future directions: toward meta-analysis of the gap junction network?

Experimental investigation of the GJN is challenging, due to the large number of putative interactions, procedural issues or the huge experimental variations caused by small sample sizes frequently found in studies using human tissues. However, meta-analyses can capitalize from the growing number of multiple microarray and other “–omics” studies publicly available. Technically, different approaches to merge and perform a statistical analysis have been established and various software tools allow users to process microarray data (Saeed et al., 2003; Gentleman et al., 2004; Reich et al., 2006; Tseng et al., 2012; Xia et al., 2013). Unfortunately, cross-comparison of studies is still a major challenge, but the recently developed online platform INMEX (Xia et al., 2013), or a LabVIEW-based software tool called Array Data Extractor (ADE) (Kurtenbach et al., 2013) are efforts toward making microarray data available in a user-friendly way to a large community. This opens the opportunity to test physiologically relevant changes of the proposed GJN in health and disease.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

This work was supported by CIHR/CRC and NSERC DG programs.

 References Abascal F. Zardoya R. (2012). LRRC8 proteins share a common ancestor with pannexins, and may form hexameric channels involved in cell-cell communication. Bioessays 34, 551–560. 10.1002/bies.20110017322532330 Abdelmohsen K. Gerber P. A. von Montfort C. Sies H. Klotz L.-O. (2003). Epidermal growth factor receptor is a common mediator of quinone-induced signaling leading to phosphorylation of connexin-43: role of glutathione and tyrosine phosphatases. J. Biol. Chem. 278, 38360–38367. 10.1074/jbc.M30678520012874275 Ai Z. Fischer A. Spray D. C. Brown A. M. Fishman G. I. (2000). Wnt-1 regulation of connexin43 in cardiac myocytes. J. Clin. Invest. 105, 161–171. 10.1172/JCI779810642594 Aleksic B. Ishihara R. Takahashi N. Maeno N. Ji X. Saito S. . (2007). Gap junction coding genes and schizophrenia: a genetic association study. J. Hum. Genet. 52, 498–501. 10.1007/s10038-007-0142-517427027 Anselmi F. Hernandez V. H. Crispino G. Seydel A. Ortolano S. Roper S. D. . (2008). ATP release through connexin hemichannels and gap junction transfer of second messengers propagate Ca2+ signals across the inner ear. Proc. Natl. Acad. Sci. U.S.A. 105, 18770–18775. 10.1073/pnas.080079310519047635 Auth T. Schlüter S. Urschel S. Kussmann P. Sonntag S. Höher T. . (2009). The TSG101 protein binds to connexins and is involved in connexin degradation. Exp. Cell Res. 315, 1053–1062. 10.1016/j.yexcr.2008.12.02519210987 Balligand J.-L. Hammond J. (2013). Protein kinase G type I in cardiac myocytes: unmasked at last? Eur. Heart J. 34, 1181–1185. 10.1093/eurheartj/ehr41522199118 Bernstein S. A. Morley G. E. (2006). Gap junctions and propagation of the cardiac action potential. Adv. Cardiol. 42, 71–85. 10.1159/00009256316646585 Bers D. M. (2010). CaMKII inhibition in heart failure makes jump to human. Circ. Res. 107, 1044–1046. 10.1161/CIRCRESAHA.110.23190221030721 Bleyl S. B. Saijoh Y. Bax N. A. M. Gittenberger-de Groot A. C. Wisse L. J. Chapman S. C. . (2010). Dysregulation of the PDGFRA gene causes inflow tract anomalies including TAPVR: integrating evidence from human genetics and model organisms. Hum. Mol. Genet. 19, 1286–1301. 10.1093/hmg/ddq00520071345 Böhm M. Gierschik P. Jakobs K. H. Pieske B. Schnabel P. Ungerer M. . (1990). Increase of Gi alpha in human hearts with dilated but not ischemic cardiomyopathy. Circulation 82, 1249–1265. Bowling N. Huang X. Sandusky G. E. Fouts R. L. Mintze K. Esterman M. . (2001). Protein kinase C-alpha and -epsilon modulate connexin-43 phosphorylation in human heart. J. Mol. Cell. Cardiol. 33, 789–798. 10.1006/jmcc.2000.134911273731 Bruce A. F. Rothery S. Dupont E. Severs N. J. (2008). Gap junction remodelling in human heart failure is associated with increased interaction of connexin43 with ZO-1. Cardiovasc. Res. 77, 757–765. 10.1093/cvr/cvm08318056766 Bruzzone S. Guida L. Zocchi E. Franco L. De Flora A. (2001). Connexin 43 hemi channels mediate Ca2+-regulated transmembrane NAD+ fluxes in intact cells. FASEB J. 15, 10–12. 10.1096/fj.00-0566fje11099492 Butkevich E. Hülsmann S. Wenzel D. Shirao T. Duden R. Majoul I. (2004). Drebrin is a novel connexin-43 binding partner that links gap junctions to the submembrane cytoskeleton. Curr. Biol. 14, 650–658. 10.1016/j.cub.2004.03.06315084279 Cameron S. J. Malik S. Akaike M. Lerner-Marmarosh N. Yan C. Lee J.-D. . (2003). Regulation of epidermal growth factor-induced connexin 43 gap junction communication by big mitogen-activated protein kinase1/ERK5 but not ERK1/2 kinase activation. J. Biol. Chem. 278, 18682–18688. 10.1074/jbc.M21328320012637502 Chanson M. Kotsias B. A. Peracchia C. O'Grady S. M. (2007). Interactions of connexins with other membrane channels and transporters. Prog. Biophys. Mol. Biol. 94, 233–244. 10.1016/j.pbiomolbio.2007.03.00217475311 Cheng H. L. Louis C. F. (1999). Endogenous casein kinase I catalyzes the phosphorylation of the lens fiber cell connexin49. Eur. J. Biochem. 263, 276–286. 10.1046/j.1432-1327.1999.00502.x10429214 Chintalgattu V. Ai D. Langley R. R. Zhang J. Bankson J. A. Shih T. L. . (2010). Cardiomyocyte PDGFR-beta signaling is an essential component of the mouse cardiac response to load-induced stress. J. Clin. Invest. 120, 472–484. 10.1172/JCI3943420071776 Chong J. J. H. Reinecke H. Iwata M. Torok-Storb B. Stempien-Otero A. Murry C. E. (2013). Progenitor cells identified by PDGFR-alpha expression in the developing and diseased human heart. Stem Cells Dev. 22, 1932–1943. 10.1089/scd.2012.054223391309 Cochrane K. Su V. Lau A. F. (2013). The connexin43-interacting protein, CIP85, mediates the internalization of connexin43 from the plasma membrane. Cell Commun. Adhes. 20, 53–66. 10.3109/15419061.2013.78474523586710 Contreras J. E. Sánchez H. A. Véliz L. P. Bukauskas F. F. Bennett M. V. L. Sáez J. C. (2004). Role of connexin-based gap junction channels and hemichannels in ischemia-induced cell death in nervous tissue. Brain Res. Brain Res. Rev. 47, 290–303. 10.1016/j.brainresrev.2004.08.00215572178 Cooper C. D. Lampe P. D. (2002). Casein kinase 1 regulates connexin-43 gap junction assembly. J. Biol. Chem. 277, 44962–44968. 10.1074/jbc.M20942720012270943 D'Angelo D. D. Sakata Y. Lorenz J. N. Boivin G. P. Walsh R. A. Liggett S. B. . (1997). Transgenic Galphaq overexpression induces cardiac contractile failure in mice. Proc. Natl. Acad. Sci. U.S.A. 94, 8121–8126. 9223325 Díez J. A. Elvira M. Villalobo A. (1998). The epidermal growth factor receptor tyrosine kinase phosphorylates connexin32. Mol. Cell. Biochem. 187, 201–210. 10.1023/A:10068846007249788758 Dizayee S. Kaestner S. Kuck F. Hein P. Klein C. Piekorz R. P. . (2011). Gαi2- and Gαi3-specific regulation of voltage-dependent L-type calcium channels in cardiomyocytes. PLoS ONE 6:e24979. 10.1371/journal.pone.002497921966394 Dubé E. Dufresne J. Chan P. T. K. Cyr D. G. (2012). Epidermal growth factor regulates connexin 43 in the human epididymis: role of gap junctions in azoospermia. Hum. Reprod. 27, 2285–2296. 10.1093/humrep/des16422611165 Edman C. F. Schulman H. (1994). Identification and characterization of delta B-CaM kinase and delta C-CaM kinase from rat heart, two new multifunctional Ca2+/calmodulin-dependent protein kinase isoforms. Biochim. Biophys. Acta 1221, 89–101. 8130281 Eom G. H. Cho Y. K. Ko J.-H. Shin S. Choe N. Kim Y. . (2011). Casein kinase-2α1 induces hypertrophic response by phosphorylation of histone deacetylase 2 S394 and its activation in the heart. Circulation 123, 2392–2403. 10.1161/CIRCULATIONAHA.110.00366521576649 Erickson J. R. Anderson M. E. (2008). CaMKII and its role in cardiac arrhythmia. J. Cardiovasc. Electrophysiol. 19, 1332–1336. 10.1111/j.1540-8167.2008.01295.x18803570 Eschenhagen T. Mende U. Nose M. Schmitz W. Scholz H. Haverich A. . (1992). Increased messenger RNA level of the inhibitory G protein alpha subunit Gi alpha-2 in human end-stage heart failure. Circ. Res. 70, 688–696. 10.1161/01.RES.70.4.6881551195 Fan G. Jiang Y.-P. Lu Z. Martin D. W. Kelly D. J. Zuckerman J. M. . (2005). A transgenic mouse model of heart failure using inducible Galpha q. J. Biol. Chem. 280, 40337–40346. 10.1074/jbc.M50681020016210321 Fatemi S. H. Folsom T. D. Reutiman T. J. Lee S. (2008). Expression of astrocytic markers aquaporin 4 and connexin 43 is altered in brains of subjects with autism. Synapse 62, 501–507. 10.1002/syn.2051918435417 Feldman A. M. (2002). Adenylyl cyclase: a new target for heart failure therapeutics. Circulation 105, 1876–1878. 10.1161/01.CIR.0000016965.24080.1211997269 Feldman A. M. Cates A. E. Veazey W. B. Hershberger R. E. Bristow M. R. Baughman K. L. . (1988). Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. J. Clin. Invest. 82, 189–197. 10.1172/JCI1135692839545 Finegold D. N. Baty C. J. Knickelbein K. Z. Perschke S. Noon S. E. Campbell D. . (2012). Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment. Clin. Cancer Res. 18, 2382–2390. 10.1158/1078-0432.CCR-11-230322351697 Finn S. (1999). Gα13 stimulates gene expression and increases cell size in cultured neonatal rat ventricular myocytes. Cardiovasc. Res. 42, 140–148. 10.1016/S0008-6363(98)00294-610435005 Fong J. T. Kells R. M. Gumpert A. M. Marzillier J. Y. Davidson M. W. Falk M. M. (2012). Internalized gap junctions are degraded by autophagy. Autophagy 8, 794–811. 10.4161/auto.1939022635056 Fortes F. S. A. Pecora I. L. Persechini P. M. Hurtado S. Costa V. Coutinho-Silva R. . (2004). Modulation of intercellular communication in macrophages: possible interactions between GAP junctions and P2 receptors. J. Cell Sci. 117, 4717–4726. 10.1242/jcs.0134515331634 Frantseva M. V. Kokarovtseva L. Naus C. G. Carlen P. L. MacFabe D. Perez Velazquez J. L. (2002). Specific gap junctions enhance the neuronal vulnerability to brain traumatic injury. J. Neurosci. 22, 644–653. 11826094 Frantz S. Klaiber M. Baba H. A. Oberwinkler H. Völker K. Gaβner B. . (2013). Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I. Eur. Heart J. 34, 1233–1244. 10.1093/eurheartj/ehr44522199120 Frey U. H. Adamzik M. Kottenberg-Assenmacher E. Jakob H. Manthey I. Broecker-Preuss M. . (2009). A novel functional haplotype in the human GNAS gene alters Galphas expression, responsiveness to beta-adrenoceptor stimulation, and peri-operative cardiac performance. Eur. Heart J. 30, 1402–1410. 10.1093/eurheartj/ehn57219136681 Fujimoto K. Nagafuchi A. Tsukita S. Kuraoka A. Ohokuma A. Shibata Y. (1997). Dynamics of connexins, E-cadherin and alpha-catenin on cell membranes during gap junction formation. J. Cell Sci. 110(pt 3), 311–322. 9057084 Furuse M. (1994). Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions. J. Cell Biol. 127, 1617–1626. 10.1083/jcb.127.6.16177798316 Gajda Z. Szupera Z. Blazsó G. Szente M. (2005). Quinine, a blocker of neuronal cx36 channels, suppresses seizure activity in rat neocortex in vivo. Epilepsia 46, 1581–1591. 10.1111/j.1528-1167.2005.00254.x16190928 Garré J. M. Retamal M. A. Cassina P. Barbeito L. Bukauskas F. F. Sáez J. C. . (2010). FGF-1 induces ATP release from spinal astrocytes in culture and opens pannexin and connexin hemichannels. Proc. Natl. Acad. Sci. U.S.A. 107, 22659–22664. 10.1073/pnas.101379310721148774 Gentleman R. C. Carey V. J. Bates D. M. Bolstad B. Dettling M. Dudoit S. . (2004). Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5, R80. 10.1186/gb-2004-5-10-r8015461798 Giepmans B. N. G. (2004). Gap junctions and connexin-interacting proteins. Cardiovasc. Res. 62, 233–245. 10.1016/j.cardiores.2003.12.00915094344 Giepmans B. N. G. Feiken E. Gebbink M. F. B. G. Moolenaar W. H. (2003). Association of connexin43 with a receptor protein tyrosine phosphatase. Cell Commun. Adhes. 10, 201–205. 10.1080/71404042714681016 Giepmans B. N. Moolenaar W. H. (1998). The gap junction protein connexin43 interacts with the second PDZ domain of the zona occludens-1 protein. Curr. Biol. 8, 931–934. 10.1016/S0960-9822(07)00375-29707407 Giepmans B. N. Verlaan I. Hengeveld T. Janssen H. Calafat J. Falk M. M. . (2001a). Gap junction protein connexin-43 interacts directly with microtubules. Curr. Biol. 11, 1364–1368. 10.1016/S0960-9822(01)00424-911553331 Giepmans B. N. Verlaan I. Moolenaar W. H. (2001b). Connexin-43 interactions with ZO-1 and alpha- and beta-tubulin. Cell Commun. Adhes. 8, 219–223. 10.3109/1541906010908072712064592 Gill S. Veinot J. Kavanagh M. Pulido O. (2007). Human heart glutamate receptors - implications for toxicology, food safety, and drug discovery. Toxicol. Pathol. 35, 411–417. 10.1080/0192623070123036117455090 Grosely R. Sorgen P. L. (2013). A history of gap junction structure: hexagonal arrays to atomic resolution. Cell Commun. Adhes. 20, 11–20. 10.3109/15419061.2013.77525623469928 Hatakeyama T. Dai P. Harada Y. Hino H. Tsukahara F. Maru Y. . (2013). Connexin43 functions as a novel interacting partner of heat shock cognate protein 70. Sci. Rep. 3, 2719. 10.1038/srep0271924056538 Hossain M. Z. Ao P. Boynton A. L. (1998a). Platelet-derived growth factor-induced disruption of gap junctional communication and phosphorylation of connexin43 involves protein kinase C and mitogen-activated protein kinase. J. Cell. Physiol. 176, 332–341. 10.1002/(SICI)1097-4652(199808)176:2<332::AID-JCP11>3.0.CO;2-59648920 Hossain M. Z. Ao P. Boynton A. L. (1998b). Rapid disruption of gap junctional communication and phosphorylation of connexin43 by platelet-derived growth factor in T51B rat liver epithelial cells expressing platelet-derived growth factor receptor. J. Cell. Physiol. 174, 66–77. 10.1002/(SICI)1097-4652(199801)174:1<66::AID-JCP8>3.0.CO;2-E9397157 Hossain M. Z. Jagdale A. B. Ao P. Boynton A. L. (1999a). Mitogen-activated protein kinase and phosphorylation of connexin43 are not sufficient for the disruption of gap junctional communication by platelet-derived growth factor and tetradecanoylphorbol acetate. J. Cell. Physiol. 179, 87–96. 10.1002/(SICI)1097-4652(199904)179:1<87::AID-JCP11>3.0.CO;2-K Hossain M. Z. Jagdale A. B. Ao P. Kazlauskas A. Boynton A. L. (1999b). Disruption of gap junctional communication by the platelet-derived growth factor is mediated via multiple signaling pathways. J. Biol. Chem. 274, 10489–10496. 10.1074/jbc.274.15.1048910187840 Huang R. Y.-C. Laing J. G. Kanter E. M. Berthoud V. M. Bao M. Rohrs H. W. . (2011). Identification of CaMKII phosphorylation sites in Connexin43 by high-resolution mass spectrometry. J. Proteome Res. 10, 1098–1109. 10.1021/pr100870221158428 Huang T. Shao Q. MacDonald A. Xin L. Lorentz R. Bai D. . (2013). Autosomal recessive GJA1 (Cx43) gene mutations cause oculodentodigital dysplasia by distinct mechanisms. J. Cell Sci. 126, 2857–2866. 10.1242/jcs.12331523606748 Hund T. J. Decker K. F. Kanter E. Mohler P. J. Boyden P. A. Schuessler R. B. . (2008). Role of activated CaMKII in abnormal calcium homeostasis and I(Na) remodeling after myocardial infarction: insights from mathematical modeling. J. Mol. Cell. Cardiol. 45, 420–428. 10.1016/j.yjmcc.2008.06.00718639555 Hwang K.-C. Lim S. Kwon H. M. Bae Y. S. Kang S.-M. Chung K.-H. . (2004). Phospholipase C-delta1 rescues intracellular Ca2+ overload in ischemic heart and hypoxic neonatal cardiomyocytes. J. Steroid Biochem. Mol. Biol. 91, 131–138. 10.1016/j.jsbmb.2004.02.00915276620 Iacobas D. A. Iacobas S. Spray D. C. (2007a). Connexin-dependent transcellular transcriptomic networks in mouse brain. Prog. Biophys. Mol. Biol. 94, 169–185. 10.1016/j.pbiomolbio.2007.03.01517507080 Iacobas D. A. Suadicani S. O. Iacobas S. Chrisman C. Cohen M. A. Spray D. C. . (2007b). Gap junction and purinergic P2 receptor proteins as a functional unit: insights from transcriptomics. J. Membr. Biol. 217, 83–91. 10.1007/s00232-007-9039-717665085 Iacobas S. Iacobas D. A. Spray D. C. Scemes E. (2012). The connexin43-dependent transcriptome during brain development: importance of genetic background. Brain Res. 1487, 131–139. 10.1016/j.brainres.2012.05.06222771707 Ichise H. Ichise T. Ohtani O. Yoshida N. (2009). Phospholipase Cgamma2 is necessary for separation of blood and lymphatic vasculature in mice. Development 136, 191–195. 10.1242/dev.02535319056831 Imanaga I. Hai L. Ogawa K. Matsumura K. Mayama T. (2004). Phosphorylation of connexin in functional regulation of the cardiac gap junction. Exp. Clin. Cardiol. 9, 161–164. 19641718 Itoh M. Morita K. Tsukita S. (1999). Characterization of ZO-2 as a MAGUK family member associated with tight as well as adherens junctions with a binding affinity to occludin and alpha catenin. J. Biol. Chem. 274, 5981–5986. 10026224 Iwase M. Uechi M. Vatner D. E. Asai K. Shannon R. P. Kudej R. K. . (1997). Cardiomyopathy induced by cardiac Gs alpha overexpression. Am. J. Physiol. 272, H585–H589. 9038982 Jansen J. A. van Veen T. A. B. de Bakker J. M. T. van Rijen H. V. M. (2010). Cardiac connexins and impulse propagation. J. Mol. Cell. Cardiol. 48, 76–82. 10.1016/j.yjmcc.2009.08.01819729017 Johnstone S. R. Billaud M. Lohman A. W. Taddeo E. P. Isakson B. E. (2012a). Posttranslational modifications in connexins and pannexins. J. Membr. Biol. 245, 319–332. 10.1007/s00232-012-9453-322739962 Johnstone S. R. Kroncke B. M. Straub A. C. Best A. K. Dunn C. A. Mitchell L. A. . (2012b). MAPK phosphorylation of connexin 43 promotes binding of cyclin E and smooth muscle cell proliferation. Circ. Res. 111, 201–211. 10.1161/CIRCRESAHA.112.27230222652908 Jongen W. M. Fitzgerald D. J. Asamoto M. Piccoli C. Slaga T. J. Gros D. . (1991). Regulation of connexin 43-mediated gap junctional intercellular communication by Ca2+ in mouse epidermal cells is controlled by E-cadherin. J. Cell Biol. 114, 545–555. 10.1083/jcb.114.3.5451650371 Jongsma H. J. Wilders R. (2000). Gap Junctions in Cardiovascular Disease. Circ. Res. 86, 1193–1197. 10.1161/01.RES.86.12.119310864907 Joshi C. N. Martin D. N. Shaver P. Madamanchi C. Muller-Borer B. J. Tulis D. A. (2012). Control of vascular smooth muscle cell growth by connexin 43. Front. Physiol. 3:220. 10.3389/fphys.2012.0022022737133 Kameritsch P. Pogoda K. Pohl U. (2012). Channel-independent influence of connexin 43 on cell migration. Biochim. Biophys. Acta 1818, 1993–2001. 10.1016/j.bbamem.2011.11.01622155212 Kanemitsu M. Y. Jiang W. Eckhart W. (1998). Cdc2-mediated phosphorylation of the gap junction protein, connexin43, during mitosis. Cell Growth Differ. 9, 13–21. 9438384 Kausalya P. J. Reichert M. Hunziker W. (2001). Connexin45 directly binds to ZO-1 and localizes to the tight junction region in epithelial MDCK cells. FEBS Lett. 505, 92–96. 10.1016/S0014-5793(01)02786-711557048 Keshet Y. Seger R. (2010). The MAP kinase signaling cascades: a system of hundreds of components regulates a diverse array of physiological functions. Methods Mol. Biol. 661, 3–38. 10.1007/978-1-60761-795-2_120811974 Kim J. Wu Q. Zhang Y. Wiens K. M. Huang Y. Rubin N. . (2010). PDGF signaling is required for epicardial function and blood vessel formation in regenerating zebrafish hearts. Proc. Natl. Acad. Sci. U.S.A. 107, 17206–17210. 10.1073/pnas.091501610720858732 Kleopa K. A. Orthmann-Murphy J. Sargiannidou I. (2010). Gap junction disorders of myelinating cells. Rev. Neurosci. 21, 397–419. 10.1515/REVNEURO.2010.21.5.39721280457 Kojima T. Sawada N. Chiba H. Kokai Y. Yamamoto M. Urban M. . (1999). Induction of tight junctions in human connexin 32 (hCx32)-transfected mouse hepatocytes: connexin 32 interacts with occludin. Biochem. Biophys. Res. Commun. 266, 222–229. 10.1006/bbrc.1999.177810581193 Kurtenbach S. Kurtenbach S. Zoidl G. (2013). Array data extractor (ADE): a LabVIEW program to extract and merge gene array data. BMC Res. Notes 6:496. 10.1186/1756-0500-6-49624289243 Kwak B. R. Sáez J. C. Wilders R. Chanson M. Fishman G. I. Hertzberg E. L. . (1995). Effects of cGMP-dependent phosphorylation on rat and human connexin43 gap junction channels. Pflugers Arch. 430, 770–778. 10.1007/BF003861757478932 Laird D. W. (2006). Life cycle of connexins in health and disease. Biochem. J. 394, 527–543. 10.1042/BJ2005192216492141 Lampe P. D. Kurata W. E. Warn-Cramer B. J. Lau A. F. (1998). Formation of a distinct connexin43 phosphoisoform in mitotic cells is dependent upon p34cdc2 kinase. J. Cell Sci. 111(pt 6), 833–841. 9472011 Lampe P. D. Lau A. F. (2004). The effects of connexin phosphorylation on gap junctional communication. Int. J. Biochem. Cell Biol. 36, 1171–1186. 10.1016/S1357-2725(03)00264-415109565 Lampe P. D. Qiu Q. Meyer R. A. TenBroek E. M. Walseth T. F. Starich T. A. . (2001). Gap junction assembly: PTX-sensitive G proteins regulate the distribution of connexin43 within cells. Am. J. Physiol. Cell Physiol. 281, C1211–C1222. 11546658 Lan Z. Kurata W. E. Martyn K. D. Jin C. Lau A. F. (2005). Novel rab GAP-like protein, CIP85, interacts with connexin43 and induces its degradation. Biochemistry 44, 2385–2396. 10.1021/bi048306w15709751 Langlois S. Cowan K. N. Shao Q. Cowan B. J. Laird D. W. (2008). Caveolin-1 and -2 interact with connexin43 and regulate gap junctional intercellular communication in keratinocytes. Mol. Biol. Cell 19, 912–928. 10.1091/mbc.E07-06-0596 Lee J. R. White T. W. (2009). Connexin-26 mutations in deafness and skin disease. Expert Rev. Mol. Med. 11, e35. 10.1017/S146239940900127619939300 Li J. Patel V. V. Kostetskii I. Xiong Y. Chu A. F. Jacobson J. T. . (2005). Cardiac-specific loss of N-cadherin leads to alteration in connexins with conduction slowing and arrhythmogenesis. Circ. Res. 97, 474–481. 10.1161/01.RES.0000181132.11393.1816100040 Li J. Shen H. Naus C. C. Zhang L. Carlen P. L. (2001). Upregulation of gap junction connexin 32 with epileptiform activity in the isolated mouse hippocampus. Neuroscience 105, 589–598. 10.1016/S0306-4522(01)00204-411516826 Li M. W. M. Mruk D. D. Lee W. M. Cheng C. Y. (2009). Connexin 43 and plakophilin-2 as a protein complex that regulates blood-testis barrier dynamics. Proc. Natl. Acad. Sci. U.S.A. 106, 10213–10218. 10.1073/pnas.090170010619509333 Li X. Lynn B. D. Nagy J. I. (2012). The effector and scaffolding proteins AF6 and MUPP1 interact with connexin36 and localize at gap junctions that form electrical synapses in rodent brain. Eur. J. Neurosci. 35, 166–181. 10.1111/j.1460-9568.2011.07947.x22211808 Lichtenstein A. Minogue P. J. Beyer E. C. Berthoud V. M. (2011). Autophagy: a pathway that contributes to connexin degradation. J. Cell Sci. 124, 910–920. 10.1242/jcs.07307221378309 Liu J. Ek Vitorin J. F. Weintraub S. T. Gu S. Shi Q. Burt J. M. . (2011a). Phosphorylation of connexin 50 by protein kinase A enhances gap junction and hemichannel function. J. Biol. Chem. 286, 16914–16928. 10.1074/jbc.M111.21873521454606 Liu J. Xu J. Gu S. Nicholson B. J. Jiang J. X. (2011b). Aquaporin 0 enhances gap junction coupling via its cell adhesion function and interaction with connexin 50. J. Cell Sci. 124, 198–206. 10.1242/jcs.07265221172802 Liu L. Li Y. Lin J. Liang Q. Sheng X. Wu J. . (2010). Connexin43 interacts with Caveolin-3 in the heart. Mol. Biol. Rep. 37, 1685–1691. 10.1007/s11033-009-9584-519544087 Liu Q. Chen X. Macdonnell S. M. Kranias E. G. Lorenz J. N. Leitges M. . (2009). Protein kinase C{alpha}, but not PKC{beta} or PKC{gamma}, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach. Circ. Res. 105, 194–200. 10.1161/CIRCRESAHA.109.195313 Lo C. W. (2000). Role of gap junctions in cardiac conduction and development: insights from the connexin knockout mice. Circ. Res. 87, 346–348. 10.1161/01.RES.87.5.34610969030 Ludwig M.-G. Seuwen K. (2002). Characterization of the human adenylyl cyclase gene family: cDNA, gene structure, and tissue distribution of the nine isoforms. J. Recept. Signal Transduct. Res. 22, 79–110. 10.1081/RRS-12001458912503609 Maeda S. Nakagawa S. Suga M. Yamashita E. Oshima A. Fujiyoshi Y. . (2009). Structure of the connexin 26 gap junction channel at 3.5 A resolution. Nature 458, 597–602. 10.1038/nature0786919340074 Majoul I. Shirao T. Sekino Y. Duden R. (2007). Many faces of drebrin: from building dendritic spines and stabilizing gap junctions to shaping neurite-like cell processes. Histochem. Cell Biol. 127, 355–361. 10.1007/s00418-007-0273-y Mangat R. Singal T. Dhalla N. S. Tappia P. S. (2006). Inhibition of phospholipase C-gamma 1 augments the decrease in cardiomyocyte viability by H2O2. Am. J. Physiol. Heart Circ. Physiol. 291, H854–H860. 10.1152/ajpheart.01205.200516501016 Márquez-Rosado L. Singh D. Rincón-Arano H. Solan J. L. Lampe P. D. (2012). CASK (LIN2) interacts with Cx43 in wounded skin and their coexpression affects cell migration. J. Cell Sci. 125, 695–702. 10.1242/jcs.08440022389404 Marx S. O. Reiken S. Hisamatsu Y. Jayaraman T. Burkhoff D. Rosemblit N. . (2000). PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101, 365–376. 10.1016/S0092-8674(00)80847-810830164 Meij J. T. Panagia V. Mesaeli N. Peachell J. L. Afzal N. Dhalla N. S. (1997). Identification of changes in cardiac phospholipase C activity in congestive heart failure. J. Mol. Cell. Cardiol. 29, 237–246. 10.1006/jmcc.1996.02689040038 Meyer J. Mai M. Ortega G. Mössner R. Lesch K.-P. (2002). Mutational analysis of the connexin 36 gene (CX36) and exclusion of the coding sequence as a candidate region for catatonic schizophrenia in a large pedigree. Schizophr. Res. 58, 87–91. 10.1016/S0920-9964(02)00206-212363395 Meyer R. A. Laird D. W. Revel J. P. Johnson R. G. (1992). Inhibition of gap junction and adherens junction assembly by connexin and A-CAM antibodies. J. Cell Biol. 119, 179–189. 10.1083/jcb.119.1.1791326565 Mitrovic V. Jovanovic A. Lehinant S. (2011). Soluble guanylate cyclase modulators in heart failure. Curr. Heart Fail. Rep. 8, 38–44. 10.1007/s11897-010-0045-121207207 Moehle M. S. Luduena R. F. Haroutunian V. Meador-Woodruff J. H. McCullumsmith R. E. (2012). Regional differences in expression of β-tubulin isoforms in schizophrenia. Schizophr. Res. 135, 181–186. 10.1016/j.schres.2011.12.01022264600 Neumann J. Schmitz W. Scholz H. von Meyerinck L. Döring V. Kalmar P. (1988). Increase in myocardial Gi-proteins in heart failure. Lancet 2, 936–937. 10.1016/S0140-6736(88)92601-32902384 Niger C. Hebert C. Stains J. P. (2010). Interaction of connexin43 and protein kinase C-delta during FGF2 signaling. BMC Biochem. 11:14. 10.1186/1471-2091-11-1420338032 Nishii K. Kumai M. Shibata Y. (2001). Regulation of the epithelial-mesenchymal transformation through gap junction channels in heart development. Trends Cardiovasc. Med. 11, 213–218. 10.1016/S1050-1738(01)00103-7 Olearczyk J. J. Stephenson A. H. Lonigro A. J. Sprague R. S. (2004). Heterotrimeric G protein Gi is involved in a signal transduction pathway for ATP release from erythrocytes. Am. J. Physiol. Heart Circ. Physiol. 286, H940–H945. 10.1152/ajpheart.00677.200314615280 Olk S. Turchinovich A. Grzendowski M. Stühler K. Meyer H. E. Zoidl G. . (2010). Proteomic analysis of astroglial connexin43 silencing uncovers a cytoskeletal platform involved in process formation and migration. Glia 58, 494–505. 10.1002/glia.2094219795503 Orellana J. A. Hernández D. E. Ezan P. Velarde V. Bennett M. V. L. Giaume C. . (2010). Hypoxia in high glucose followed by reoxygenation in normal glucose reduces the viability of cortical astrocytes through increased permeability of connexin 43 hemichannels. Glia 58, 329–343. 10.1002/glia.2092619705457 Otaegui D. Querejeta R. Arrieta A. Lazkano A. Bidaurrazaga A. Arriandiaga J. R. . (2010). Phospholipase Cbeta4 isozyme is expressed in human, rat, and murine heart left ventricles and in HL-1 cardiomyocytes. Mol. Cell. Biochem. 337, 167–173. 10.1007/s11010-009-0296-x19856080 Ouyang X. Winbow V. M. Patel L. S. Burr G. S. Mitchell C. K. O'Brien J. (2005). Protein kinase A mediates regulation of gap junctions containing connexin35 through a complex pathway. Brain Res. Mol. Brain Res. 135, 1–11. 10.1016/j.molbrainres.2004.10.04515857663 Palaniyandi S. S. Sun L. Ferreira J. C. B. Mochly-Rosen D. (2009). Protein kinase C in heart failure: a therapeutic target? Cardiovasc. Res. 82, 229–239. 10.1093/cvr/cvp00119168855 Patel L. S. Mitchell C. K. Dubinsky W. P. O'Brien J. (2006). Regulation of gap junction coupling through the neuronal connexin Cx35 by nitric oxide and cGMP. Cell Commun. Adhes. 13, 41–54. 10.1080/1541906060063147416613779 Patel Y. M. Patel K. Rahman S. Smith M. P. Spooner G. Sumathipala R. . (2003). Evidence for a role for Galphai1 in mediating weak agonist-induced platelet aggregation in human platelets: reduced Galphai1 expression and defective Gi signaling in the platelets of a patient with a chronic bleeding disorder. Blood 101, 4828–4835. 10.1182/blood-2002-10-308012609843 Peracchia C. Sotkis A. Wang X. G. Peracchia L. L. Persechini A. (2000). Calmodulin directly gates gap junction channels. J. Biol. Chem. 275, 26220–26224. 10.1074/jbc.M00400720010852921 Potenza N. Vecchione C. Notte A. De Rienzo A. Rosica A. Bauer L. . (2005). Replacement of K-Ras with H-Ras supports normal embryonic development despite inducing cardiovascular pathology in adult mice. EMBO Rep. 6, 432–437. 10.1038/sj.embor.740039715864294 Reich M. Liefeld T. Gould J. Lerner J. Tamayo P. Mesirov J. P. (2006). GenePattern 2.0. Nat. Genet. 38, 500–501. 10.1038/ng0506-50016642009 Rhett J. M. Jourdan J. Gourdie R. G. (2011). Connexin 43 connexon to gap junction transition is regulated by zonula occludens-1. Mol. Biol. Cell 22, 1516–1528. 10.1091/mbc.E10-06-054821411628 Rodríguez-Sinovas A. Sánchez J. A. Fernandez-Sanz C. Ruiz-Meana M. Garcia-Dorado D. (2012). Connexin and pannexin as modulators of myocardial injury. Biochim. Biophys. Acta 1818, 1962–1970. 10.1016/j.bbamem.2011.07.04121839721 Rohr S. (2004). Role of gap junctions in the propagation of the cardiac action potential. Cardiovasc. Res. 62, 309–322. 10.1016/j.cardiores.2003.11.03515094351 Rose B. A. Force T. Wang Y. (2010). Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol. Rev. 90, 1507–1546. 10.1152/physrev.00054.200920959622 Rutkovskiy A. Valen G. Vaage J. (2013). Cardiac aquaporins. Basic Res. Cardiol. 108, 393. 10.1007/s00395-013-0393-624158693 Rutledge C. Ng F. Sulkin M. Greener I. Arasu D. Gemel J. . (2012). c-Src regulation of Connexin43 remodeling in ischemic heart disease. Heart Rhythm 9, 1910. 10.1016/j.hrthm.2012.09.093 Saeed A. I. Sharov V. White J. Li J. Liang W. Bhagabati N. . (2003). TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34, 374–378. 12613259 Samoilova M. Wentlandt K. Adamchik Y. Velumian A. A. Carlen P. L. (2008). Connexin 43 mimetic peptides inhibit spontaneous epileptiform activity in organotypic hippocampal slice cultures. Exp. Neurol. 210, 762–775. 10.1016/j.expneurol.2008.01.00518284929 Sato M. Jiao Q. Honda T. Kurotani R. Toyota E. Okumura S. . (2009). Activator of G protein signaling 8 (AGS8) is required for hypoxia-induced apoptosis of cardiomyocytes: role of G betagamma and connexin 43 (CX43). J. Biol. Chem. 284, 31431–31440. 10.1074/jbc.M109.01406819723622 Sato P. Y. Coombs W. Lin X. Nekrasova O. Green K. J. Isom L. L. . (2011). Interactions between ankyrin-G, Plakophilin-2, and Connexin43 at the cardiac intercalated disc. Circ. Res. 109, 193–201. 10.1161/CIRCRESAHA.111.24702321617128 Schatteman G. C. Motley S. T. Effmann E. L. Bowen-Pope D. F. (1995). Platelet-derived growth factor receptor alpha subunit deleted Patch mouse exhibits severe cardiovascular dysmorphogenesis. Teratology 51, 351–366. 10.1002/tera.14205106027502236 Scherer S. S. Kleopa K. A. (2012). X-linked charcot-marie-tooth disease. J. Peripher. Nerv. Syst. 17(Suppl. 3), 9–13. 10.1111/j.1529-8027.2012.00424.x23279425 Schwertz D. W. Halverson J. (1992). Changes in phosphoinositide-specific phospholipase C and phospholipase A2 activity in ischemic and reperfused rat heart. Basic Res. Cardiol. 87, 113–127. 10.1007/BF008019591590734 Schworer C. M. Rothblum L. I. Thekkumkara T. J. Singer H. A. (1993). Identification of novel isoforms of the delta subunit of Ca2+/calmodulin-dependent protein kinase II. Differential expression in rat brain and aorta. J. Biol. Chem. 268, 14443–14449. 8390994 Severs N. J. (2001). Gap junction remodeling and cardiac arrhythmogenesis: cause or coincidence? J. Cell. Mol. Med. 5, 355–366. 10.1111/j.1582-4934.2001.tb00170.x Severs N. J. Bruce A. F. Dupont E. Rothery S. (2008). Remodelling of gap junctions and connexin expression in diseased myocardium. Cardiovasc. Res. 80, 9–19. 10.1093/cvr/cvn13318519446 Severs N. J. Coppen S. R. Dupont E. Yeh H.-I. Ko Y.-S. Matsushita T. (2004). Gap junction alterations in human cardiac disease. Cardiovasc. Res. 62, 368–377. 10.1016/j.cardiores.2003.12.00715094356 Shen W. Li L. Song B. Li W. Zhou Z. Guo R. (2013). Platelet-derived growth factor-BB increases expression of connexin 43 in an extracellular-regulated protein kinase-dependent manner in bladder smooth muscle cells. Int. J. Urol. 20, 123–130. 10.1111/j.1442-2042.2012.03192.x Singh D. Solan J. L. Taffet S. M. Javier R. Lampe P. D. (2005). Connexin 43 interacts with zona occludens-1 and -2 proteins in a cell cycle stage-specific manner. J. Biol. Chem. 280, 30416–30421. 10.1074/jbc.M50679920015980428 Smyth J. W. Vogan J. M. Buch P. J. Zhang S.-S. Fong T. S. Hong T.-T. . (2012). Actin cytoskeleton rest stops regulate anterograde traffic of connexin 43 vesicles to the plasma membrane. Circ. Res. 110, 978–989. 10.1161/CIRCRESAHA.111.25796422328533 Söhl G. Maxeiner S. Willecke K. (2005). Expression and functions of neuronal gap junctions. Nat. Rev. Neurosci. 6, 191–200. 10.1038/nrn162715738956 Solan J. L. Lampe P. D. (2005). Connexin phosphorylation as a regulatory event linked to gap junction channel assembly. Biochim. Biophys. Acta 1711, 154–163. 10.1016/j.bbamem.2004.09.01315955300 Spray D. C. Iacobas D. A. (2007). Organizational principles of the connexin-related brain transcriptome. J. Membr. Biol. 218, 39–47. 10.1007/s00232-007-9049-517657523 Su V. Cochrane K. Lau A. F. (2012). Degradation of connexins through the proteasomal, endolysosomal and phagolysosomal pathways. J. Membr. Biol. 245, 389–400. 10.1007/s00232-012-9461-322772442 Sun Y. Zhao X. Yao Y. Qi X. Yuan Y. Hu Y. (2012). Connexin 43 interacts with Bax to regulate apoptosis of pancreatic cancer through a gap junction-independent pathway. Int. J. Oncol. 41, 941–948. 10.3892/ijo.2012.152422736223 Takasago T. Imagawa T. Furukawa K. Ogurusu T. Shigekawa M. (1991). Regulation of the cardiac ryanodine receptor by protein kinase-dependent phosphorylation. J. Biochem. 109, 163–170. 1849885 Takefuji M. Wirth A. Lukasova M. Takefuji S. Boettger T. Braun T. . (2012). G13-mediated signaling pathway is required for pressure overload-induced cardiac remodeling and heart failure. Circulation 126, 1972–1982. 10.1161/CIRCULATIONAHA.112.10925622972902 Talhouk R. S. Zeinieh M. P. Mikati M. A. El-Sabban M. E. (2008). Gap junctional intercellular communication in hypoxia-ischemia-induced neuronal injury. Prog. Neurobiol. 84, 57–76. 10.1016/j.pneurobio.2007.10.00118006137 Thévenin A. F. Kowal T. J. Fong J. T. Kells R. M. Fisher C. G. Falk M. M. . (2013). Proteins and mechanisms regulating gap-junction assembly, internalization, and degradation. Physiology (Bethesda) 28, 93–116. 10.1152/physiol.00038.201223455769 Toyofuku T. Akamatsu Y. Zhang H. Kuzuya T. Tada M. Hori M. . (2001). c-Src regulates the interaction between connexin-43 and ZO-1 in cardiac myocytes. J. Biol. Chem. 276, 1780–1788. 10.1074/jbc.M00582620011035005 Toyofuku T. Yabuki M. Otsu K. Kuzuya T. Hori M. Tada M. . (1998). Direct association of the gap junction protein connexin-43 with ZO-1 in cardiac myocytes. J. Biol. Chem. 273, 12725–12731. 10.1074/jbc.273.21.127259582296 Tribulová N. Knezl V. Okruhlicová L. Slezák J. (2008). Myocardial gap junctions: targets for novel approaches in the prevention of life-threatening cardiac arrhythmias. Physiol. Res. 57(Suppl. 2), S1–S13. 18373398 Tseng G. C. Ghosh D. Feingold E. (2012). Comprehensive literature review and statistical considerations for microarray meta-analysis. Nucleic Acids Res. 40, 3785–3799. 10.1093/nar/gkr126522262733 Urschel S. Höher T. Schubert T. Alev C. Söhl G. Wörsdörfer P. . (2006). Protein kinase A-mediated phosphorylation of connexin36 in mouse retina results in decreased gap junctional communication between AII amacrine cells. J. Biol. Chem. 281, 33163–33171. 10.1074/jbc.M60639620016956882 Van den Akker N. M. S. Winkel L. C. J. Nisancioglu M. H. Maas S. Wisse L. J. Armulik A. . (2008). PDGF-B signaling is important for murine cardiac development: its role in developing atrioventricular valves, coronaries, and cardiac innervation. Dev. Dyn. 237, 494–503. 10.1002/dvdy.2143618213589 Van Zeijl L. Ponsioen B. Giepmans B. N. G. Ariaens A. Postma F. R. Várnai P. . (2007). Regulation of connexin43 gap junctional communication by phosphatidylinositol 4,5-bisphosphate. J. Cell Biol. 177, 881–891. 10.1083/jcb.20061014417535964 Verheule S. Kaese S. (2013). Connexin diversity in the heart: insights from transgenic mouse models. Front. Pharmacol. 4:81. 10.3389/fphar.2013.0008123818881 Vessey D. A. Li L. Kelley M. (2010). Pannexin-I/P2X 7 purinergic receptor channels mediate the release of cardioprotectants induced by ischemic pre- and postconditioning. J. Cardiovasc. Pharmacol. Ther. 15, 190–195. 10.1177/107424840936035620200324 Vessey D. A. Li L. Kelley M. (2011). Ischemic preconditioning requires opening of pannexin-1/P2X(7) channels not only during preconditioning but again after index ischemia at full reperfusion. Mol. Cell. Biochem. 351, 77–84. 10.1007/s11010-011-0713-921267638 Vinken M. Decrock E. Leybaert L. Bultynck G. Himpens B. Vanhaecke T. . (2012). Non-channel functions of connexins in cell growth and cell death. Biochim. Biophys. Acta 1818, 2002–2008. 10.1016/j.bbamem.2011.06.01121718687 Wall M. E. Otey C. Qi J. Banes A. J. (2007). Connexin 43 is localized with actin in tenocytes. Cell Motil. Cytoskeleton 64, 121–130. 10.1002/cm.2017017183550 Wang X.-H. Streeter M. Liu Y.-P. Zhao H.-B. (2009). Identification and characterization of pannexin expression in the mammalian cochlea. J. Comp. Neurol. 512, 336–346. 10.1002/cne.21898 Wettschureck N. Rütten H. Zywietz A. Gehring D. Wilkie T. M. Chen J. . (2001). Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Galphaq/Galpha11 in cardiomyocytes. Nat. Med. 7, 1236–1240. 10.1038/nm1101-123611689889 Winter C. R. Baker R. C. (1995). L-glutamate-induced changes in intracellular calcium oscillation frequency through non-classical glutamate receptor binding in cultured rat myocardial cells. Life Sci. 57, 1925–1934. 10.1016/0024-3205(95)02179-M7475942 Xia J. Fjell C. D. Mayer M. L. Pena O. M. Wishart D. S. Hancock R. E. W. (2013). INMEX–a web-based tool for integrative meta-analysis of expression data. Nucleic Acids Res. 41, W63–W70. 10.1093/nar/gkt33823766290 Xu J. Nicholson B. J. (2013). The role of connexins in ear and skin physiology - functional insights from disease-associated mutations. Biochim. Biophys. Acta 1828, 167–178. 10.1016/j.bbamem.2012.06.02422796187 Xu X. Li W. E. Huang G. Y. Meyer R. Chen T. Luo Y. . (2001). Modulation of mouse neural crest cell motility by N-cadherin and connexin 43 gap junctions. J. Cell Biol. 154, 217–230. 10.1083/jcb.20010504711449002 Yin X. (2000). Casein Kinase II Phosphorylates Lens Connexin 45.6 and is involved in its degradation. J. Biol. Chem. 275, 6850–6856. 10.1074/jbc.275.10.685010702244 Yu X. S. Jiang J. X. (2004). Interaction of major intrinsic protein (aquaporin-0) with fiber connexins in lens development. J. Cell Sci. 117, 871–880. 10.1242/jcs.0094514762116 Yu X. S. Yin X. Lafer E. M. Jiang J. X. (2005). Developmental regulation of the direct interaction between the intracellular loop of connexin 45.6 and the C terminus of major intrinsic protein (aquaporin-0). J. Biol. Chem. 280, 22081–22090. 10.1074/jbc.M41437720015802270 Zacchigna S. Oh H. Wilsch-Bräuninger M. Missol-Kolka E. Jászai J. Jansen S. . (2009). Loss of the cholesterol-binding protein prominin-1/CD133 causes disk dysmorphogenesis and photoreceptor degeneration. J. Neurosci. 29, 2297–2308. 10.1523/JNEUROSCI.2034-08.200919228982 Zemljic-Harpf A. E. Godoy J. Platoshyn O. Asfaw E. K. Busija A. R. Domenighetti A. A. . (2014). Vinculin directly binds zonula occludens-1 and is essential for stabilizing connexin 43 containing gap junctions in cardiac Myocytes. J. Cell Sci. [Epub ahead of print]. 10.1242/jcs.14374324413171 Zemljic-Harpf A. E. Miller J. C. Henderson S. A. Wright A. T. Manso A. M. Elsherif L. . (2007). Cardiac-myocyte-specific excision of the vinculin gene disrupts cellular junctions, causing sudden death or dilated cardiomyopathy. Mol. Cell. Biol. 27, 7522–7537. 10.1128/MCB.00728-07 Zhang F. Cheng J. Lam G. Jin D. K. Vincent L. Hackett N. R. . (2005). Adenovirus vector E4 gene regulates connexin 40 and 43 expression in endothelial cells via PKA and PI3K signal pathways. Circ. Res. 96, 950–957. 10.1161/01.RES.0000165867.95291.7b15831817 Zou J. Salarian M. Chen Y. Veenstra R. Louis C. F. Yang J. J. (2014). Gap junction regulation by calmodulin. FEBS Lett. 10.1016/j.febslet.2014.01.003. [Epub ahead of print]. Zuberi Z. Birnbaumer L. Tinker A. (2008). The role of inhibitory heterotrimeric G proteins in the control of in vivo heart rate dynamics. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295, R1822–R1830. 10.1152/ajpregu.90625.200818832081